563 related articles for article (PubMed ID: 28430817)
21. Upregulation of MicroRNA 711 Mediates HIV-1 Vpr Promotion of Kaposi's Sarcoma-Associated Herpesvirus Latency and Induction of Pro-proliferation and Pro-survival Cytokines by Targeting the Notch/NF-κB-Signaling Axis.
Yan Q; Zhao R; Shen C; Wang F; Li W; Gao SJ; Lu C
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976660
[TBL] [Abstract][Full Text] [Related]
22. Single molecule analysis of replicated DNA reveals the usage of multiple KSHV genome regions for latent replication.
Verma SC; Lu J; Cai Q; Kosiyatrakul S; McDowell ME; Schildkraut CL; Robertson ES
PLoS Pathog; 2011 Nov; 7(11):e1002365. PubMed ID: 22072974
[TBL] [Abstract][Full Text] [Related]
23. Effects of the NEDD8-Activating Enzyme Inhibitor MLN4924 on Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus.
Chang PJ; Chen LW; Chen LY; Hung CH; Shih YJ; Wang SS
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701396
[TBL] [Abstract][Full Text] [Related]
24. The single RBP-Jkappa site within the LANA promoter is crucial for establishing Kaposi's sarcoma-associated herpesvirus latency during primary infection.
Lu J; Verma SC; Cai Q; Robertson ES
J Virol; 2011 Jul; 85(13):6148-61. PubMed ID: 21507979
[TBL] [Abstract][Full Text] [Related]
25. Kaposi's sarcoma-associated herpesvirus-encoded LANA recruits topoisomerase IIβ for latent DNA replication of the terminal repeats.
Purushothaman P; McDowell ME; McGuinness J; Salas R; Rumjahn SM; Verma SC
J Virol; 2012 Sep; 86(18):9983-94. PubMed ID: 22761383
[TBL] [Abstract][Full Text] [Related]
26. Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen inhibits interferon (IFN) beta expression by competing with IFN regulatory factor-3 for binding to IFNB promoter.
Cloutier N; Flamand L
J Biol Chem; 2010 Mar; 285(10):7208-21. PubMed ID: 20048166
[TBL] [Abstract][Full Text] [Related]
27. KSHV LANA acetylation-selective acidic domain reader sequence mediates virus persistence.
Juillard F; de Miranda MP; Li S; Franco A; Seixas AF; Liu B; Álvarez ÁL; Tan M; Szymula A; Kaye KM; Simas JP
Proc Natl Acad Sci U S A; 2020 Sep; 117(36):22443-22451. PubMed ID: 32820070
[TBL] [Abstract][Full Text] [Related]
28. The Kaposi Sarcoma Herpesvirus Latency-associated Nuclear Antigen DNA Binding Domain Dorsal Positive Electrostatic Patch Facilitates DNA Replication and Episome Persistence.
Li S; Tan M; Juillard F; Ponnusamy R; Correia B; Simas JP; Carrondo MA; McVey CE; Kaye KM
J Biol Chem; 2015 Nov; 290(47):28084-28096. PubMed ID: 26420481
[TBL] [Abstract][Full Text] [Related]
29. Kaposi's Sarcoma-Associated Herpesvirus LANA-Adjacent Regions with Distinct Functions in Episome Segregation or Maintenance.
Juillard F; De León Vázquez E; Tan M; Li S; Kaye KM
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626680
[TBL] [Abstract][Full Text] [Related]
30. BET-Inhibitors Disrupt Rad21-Dependent Conformational Control of KSHV Latency.
Chen HS; De Leo A; Wang Z; Kerekovic A; Hills R; Lieberman PM
PLoS Pathog; 2017 Jan; 13(1):e1006100. PubMed ID: 28107481
[TBL] [Abstract][Full Text] [Related]
31. NDRG1 facilitates the replication and persistence of Kaposi's sarcoma-associated herpesvirus by interacting with the DNA polymerase clamp PCNA.
Zhang F; Liang D; Lin X; Zou Z; Sun R; Wang X; Liang X; Kaye KM; Lan K
PLoS Pathog; 2019 Feb; 15(2):e1007628. PubMed ID: 30811506
[TBL] [Abstract][Full Text] [Related]
32. The Expression and Nuclear Retention Element of Polyadenylated Nuclear RNA Is Not Required for Productive Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus.
Gutierrez IV; Dayton J; Harger S; Rossetto CC
J Virol; 2021 Jun; 95(13):e0009621. PubMed ID: 33853955
[TBL] [Abstract][Full Text] [Related]
33. Kaposi's sarcoma-associated herpesvirus LANA hitches a ride on the chromosome.
Barbera AJ; Chodaparambil JV; Kelley-Clarke B; Luger K; Kaye KM
Cell Cycle; 2006 May; 5(10):1048-52. PubMed ID: 16721045
[TBL] [Abstract][Full Text] [Related]
34. Nuclear Localization and Cleavage of STAT6 Is Induced by Kaposi's Sarcoma-Associated Herpesvirus for Viral Latency.
Wang C; Zhu C; Wei F; Gao S; Zhang L; Li Y; Feng Y; Tong Y; Xu J; Wang B; Yuan Z; Robertson ES; Cai Q
PLoS Pathog; 2017 Jan; 13(1):e1006124. PubMed ID: 28099521
[TBL] [Abstract][Full Text] [Related]
35. T-cell immunity to Kaposi sarcoma-associated herpesvirus: recognition of primary effusion lymphoma by LANA-specific CD4+ T cells.
Sabbah S; Jagne YJ; Zuo J; de Silva T; Ahasan MM; Brander C; Rowland-Jones S; Flanagan KL; Hislop AD
Blood; 2012 Mar; 119(9):2083-92. PubMed ID: 22234686
[TBL] [Abstract][Full Text] [Related]
36. Kaposi's sarcoma-associated herpesvirus-encoded LANA interacts with host KAP1 to facilitate establishment of viral latency.
Sun R; Liang D; Gao Y; Lan K
J Virol; 2014 Jul; 88(13):7331-44. PubMed ID: 24741090
[TBL] [Abstract][Full Text] [Related]
37. Kaposi's sarcoma-associated herpesvirus LANA recruits the DNA polymerase clamp loader to mediate efficient replication and virus persistence.
Sun Q; Tsurimoto T; Juillard F; Li L; Li S; De León Vázquez E; Chen S; Kaye K
Proc Natl Acad Sci U S A; 2014 Aug; 111(32):11816-21. PubMed ID: 25071216
[TBL] [Abstract][Full Text] [Related]
38. Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency.
Sarek G; Järviluoma A; Moore HM; Tojkander S; Vartia S; Biberfeld P; Laiho M; Ojala PM
PLoS Pathog; 2010 Mar; 6(3):e1000818. PubMed ID: 20333249
[TBL] [Abstract][Full Text] [Related]
39. Kaposi's sarcoma-associated herpesvirus terminal repeat regulates inducible lytic gene promoters.
Izumiya Y; Algalil A; Espera JM; Miura H; Izumiya C; Inagaki T; Kumar A
J Virol; 2024 Feb; 98(2):e0138623. PubMed ID: 38240593
[TBL] [Abstract][Full Text] [Related]
40. Differences in Kaposi sarcoma-associated herpesvirus-specific and herpesvirus-non-specific immune responses in classic Kaposi sarcoma cases and matched controls in Sicily.
Amodio E; Goedert JJ; Barozzi P; Riva G; Firenze A; Bonura F; Viviano E; Romano N; Luppi M
Cancer Sci; 2011 Oct; 102(10):1769-73. PubMed ID: 21740480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
